Table 7.
Group* | Estimate | Standard Error | df | T | p-value |
---|---|---|---|---|---|
HIV− GG | 0.4262 | 0.1213 | 3987 | 3.51 | 0.0004 |
HIV+ GG | 0.6181 | 0.1329 | 4204 | 4.65 | <.0001 |
HIV− AA/AG | 0.9042 | 0.1938 | 4032 | 4.66 | <.0001 |
HIV+ AA/AG | 0.4951 | 0.1728 | 4163 | 2.87 | 0.0042 |
| |||||
Post Hoc Comparisons** | |||||
| |||||
HIV− GG vs. HIV− AA/AG | −0.4780 | 0.1934 | 4032 | −2.47 | 0.0135 |
HIV− AA/AG vs. HIV+ AA/AG | 0.4091 | 0.2004 | 4116 | 2.04 | 0.0413 |
All cases included regardless of stimulant use status
Only significant results are shown